Versallies Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
About Versallies Biotech
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Awel, Anilkumar, and Sneha Awel serve as directors at the Company.
- CIN/LLPIN
U74999MH2015PTC267695
- Company No.
267695
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2015
- Date of AGM
26 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Versallies Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Awel  | Director | 06-Jan-2023 | Current |
| Anilkumar | Director | 25-Jul-2023 | Current |
| Sneha Awel | Additional Director | 24-Sep-2024 | Current |
Financial Performance of Versallies Biotech.
Versallies Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Versallies Biotech?
In 2017, Versallies Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Versallies India Private LimitedActive 12 years 7 monthsSatish Awel and . Anilkumar are mutual person
- Versallies Offshore Private LimitedActive 12 years 28 days
Satish Awel, . Anilkumar and 1 more are mutual person
- Versallies Retail Private LimitedActive 9 years 3 months
Satish Awel, . Anilkumar and 1 more are mutual person
- Versallies Wellness Private LimitedActive 9 years 3 months
Satish Awel, . Anilkumar and 1 more are mutual person
- Versallies Biosciences Private LimitedActive 9 years 3 months
Satish Awel, . Anilkumar and 1 more are mutual person
- Versallies Ventures Private LimitedActive 10 years 14 days
Satish Awel, . Anilkumar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Versallies Biotech?
Unlock and access historical data on people associated with Versallies Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Versallies Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Versallies Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
